WHA28.65  Good  practices  in the manufacture  and  quality  control  of drugs  and  certification  scheme  on the 
quality  of pharmaceutical  products  moving  in international  commerce 
The Twenty-eighth  World  Health  Assembly, 
Recalling  resolutions  WHA22.50,  WHA23.45  and  WHA25.61; 
Having  noted  resolution  EB55.R21  ； 
Having  examined  the report  of the Director-General  on prophylactic  and  therapeutic  substances, 
1. ADOPTS  the revised  texts  of the "Good  practices  in the manufacture  and  quality  control  of drugs"  and 
the "Certification  scheme  on the  quality  of pharmaceutical  products  moving  in international  commerce", 
as appended  to the report;1 
2. RECOMMENDS  that  Member  States  : 
(1) apply  the  revised  requirements  for  “Good  practices  in the  manufacture  and  quality  control  of 
drugs"  as formulated  in the report  of the Director-General  ； 
(2) participate  in the revised  "Certification  scheme  on the quality  of pharmaceutical  products  moving 
in international  commerce"  as formulated  in the report  of the Director-General  ； and 
3. REQUESTS  the Director-General  to report  to A future  World  Health  Assembly  on the implementation  of 
the above  recommendations. 
Handb.  Res.,  Vol.  II，1.10.1 Thirteenth  plenary  meeting,  29 May  1975 
(Committee  B,  seventh  report) 
